Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
EGFR mutation + MET overexpression
i
Other names:
DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase, EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Associations
(3)
News
Trials
C3 | Sensitive
C3 | Resistant
Show legend
Drug categories
EGFR
Tyrosine Kinase Inhibitors
Chemotherapy
Cancel
Non Small Cell Lung Cancer
gefitinib + tepotinib
C3
EGFR mutation + MET overexpression
|
Non Small Cell Lung Cancer
|
gefitinib + tepotinib
osimertinib + ABBV-399
C3
EGFR mutation + MET overexpression
|
Non Small Cell Lung Cancer
|
osimertinib + ABBV-399
EGFR inhibitor
C3
EGFR mutation + MET overexpression
|
Non Small Cell Lung Cancer
|
EGFR inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login